Sean Murphy
Director of Finance/CFO at TRISALUS LIFE SCIENCES, INC.
Net worth: 5 M $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
George Martin | M | 65 |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin.
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | 10 years |
Mary Szela | F | 60 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 32 years |
Adrian Howd | M | 52 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | 4 years |
Andrew von Eschenbach | M | 82 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Robert Funck | M | 62 | 37 years | |
Mark Gergen | M | 61 | 6 years | |
Jeffrey Binder | M | 60 | 11 years | |
Rudy Mareel | M | 61 |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | 6 years |
John Oliver Thomas Given | M | 54 |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | 10 years |
Kathryn Collins | F | - | 25 years | |
Jean-Michel Cossery | M | 65 |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | 6 years |
Bobby Reddy | M | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | - |
Robert J. Schotzinger | M | 63 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Kerry Hicks | M | 64 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 1 years |
Anil Singhal | M | 72 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 6 years |
Edward A. Ogunro | M | 71 |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 2 years |
William Daniel | M | 72 | 9 years | |
Mats Wahlström | M | 70 |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | 7 years |
Scott House | M | - | 34 years | |
Harry Leonhardt | M | 67 | 4 years | |
Guillermo A. Herrera | M | 70 |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | - |
Hubert Allen | M | 58 | 18 years | |
Luke Corning | M | 41 | 4 years | |
Dominique G. Petitgenet | M | 62 | 12 years | |
Mark Stibich | M | - |
Xenex Disinfection Services, Inc.
Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | 16 years |
Philip Boudreau | M | 51 | 27 years | |
Loren Wagner | M | - | 3 years | |
Kristin Martin | F | 49 | 5 years | |
Arjun Desai | M | 42 | 1 years | |
Scott Leinenweber | M | - | 27 years | |
Sarah Thailing | F | - | 4 years | |
Robert Alpern | M | 73 | 16 years | |
Jeffrey Edwards | M | 63 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | - |
Peter A. Schwartzman | M | - | 4 years | |
Margaret Mary Taylor | F | 67 | 17 years | |
Avi Pelossof | M | - | 6 years | |
John Schmid | M | 61 | 6 years | |
Kirsten Drejer | M | 68 | 4 years | |
Morris Miller | M | - |
Xenex Disinfection Services, Inc.
Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | - |
S. Torres | M | 61 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Marcea Lloyd | F | 75 | 5 years | |
Scott Garrett | M | 74 | - | |
David Matlin | M | 62 | 1 years | |
Philip R. Tracy | M | 81 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 9 years |
Jodi Devlin | F | - | 1 years | |
Lisa Portale | F | - | 5 years | |
Steven Katz | M | 49 | 1 years | |
Kendall Lioon | F | - | 5 years | |
Julia Monfrini Peev | F | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 3 years |
Bryan Cox | M | 62 | 1 years | |
Karen Basbaum | F | - | 4 years | |
Mark T. Wagner | M | 67 |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | 2 years |
Richard Marshak | M | 65 | 1 years | |
Steve D. Weinstein | M | - |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | - |
James Alecxih | M | 59 | 1 years | |
Jennifer Stevens | F | 63 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paula Stafford | F | 60 | 6 years | |
Owen Hughes | M | 49 | 9 years | |
Daniel Dolan | M | 47 | 4 years | |
Jeffrey Leiden | M | 68 | 6 years | |
A. Sanders | F | 60 | 6 years | |
Darragh Lyons | M | 43 |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | 9 years |
Miles White | M | 69 | 37 years | |
Donal O'Connor | M | 73 | 1 years | |
Kyran McLaughlin | M | 80 | 2 years | |
William Hawkins | M | 70 | 4 years | |
Holger Liepmann | M | 72 |
Altan Pharma Ltd.
Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | 32 years |
Nishan de Silva | M | 51 | 3 years | |
Eugene Sun | M | 65 | 15 years | |
Elaine R. Leavenworth | F | 65 | 27 years | |
Averi Price | F | - | 6 years | |
Jose Carmona | M | 51 | 3 years | |
Neil McLoughlin | M | - | 3 years | |
Fred B. Parks | M | 76 | 1 years | |
James Chopas | M | 57 | 3 years | |
John Gay | M | 47 | 5 years | |
Mark Conley | M | 62 | 2 years | |
Tomoko Maeda-Chubachi | M | - | 6 years | |
Steven N. Gersten | M | - | 11 years | |
Jemma Hogan | F | - | - | |
Brian Yoor | M | 54 | 23 years | |
Mark Schoenfisch | M | - | 10 years | |
Todd C. Bennett | M | 54 | 5 years | |
Andrew Novak | M | 42 | 7 years | |
Jack Schuler | M | 83 | 17 years | |
Richard Peterson | M | 56 | 2 years | |
Roxanne Austin | F | 63 | 22 years | |
Thomas Joseph Dee | M | 60 | 23 years | |
William E. Nielsen | M | 77 |
Western Illinois University
| 5 years |
Tom R. Hodgson | M | 82 | 27 years | |
William Osborn | M | 76 | 15 years | |
Robert Parkinson | M | 73 | 25 years | |
Glenn Tilton | M | 75 | 16 years | |
Robert Keegan | M | 76 | 7 years | |
Kent Geer | M | 70 | 8 years | |
Philip Moise | M | 74 | 5 years | |
Laura Schumacher | F | 60 | 5 years | |
Marshall V. Laitsch | M | 75 |
Western Illinois University
| 7 years |
David A. L. Owen | M | 85 | - | |
David Hirsch | M | 53 | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 89 | 89.00% |
Ireland | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sean Murphy
- Personal Network